ID   B407
AC   CVCL_L601
DR   Wikidata; Q54752673
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10848782;
CC   Population: Japanese.
CC   Doubling time: ~32 hours (PubMed=10848782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5842 ! MOLP-5
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=10848782; DOI=10.1046/j.1365-2141.2000.01985.x;
RA   Matsuo Y., Drexler H.G., Nishizaki C., Harashima A., Fukuda S.,
RA   Kozuka T., Sezaki T., Orita K.;
RT   "Human bone marrow stroma-dependent cell line MOLP-5 derived from a
RT   patient in leukaemic phase of multiple myeloma.";
RL   Br. J. Haematol. 109:54-63(2000).
//